Tiffany Westrich-Robertson is the CEO and original founder of AiArthritis (the International Foundation for Autoimmune & Autoinflammatory Arthritis) and a person living with axial spondyloarthritis. She also leads the Ensuring Access through Collaborative Health (EACH) and associated Patient Inclusion Council (PIC), a national, two-part, disease agnostic coalition advocating for drug affordability policies that benefit patients. She serves on many advisory panels, including the Center for Innovation & Value Research Patient Council and is the Patient Co-Chair for the ICER Patient Council. Tiffany has been enlisted as a speaker as both a panelist and moderator on the topic of prescription drug affordability and patient engagement in associated activities since 2023. Some recent examples include: October 2025: Center for Innovation & Value Research - International Reference Pricing, Health Technology Assessment, and Patient-Centered Health September 2025: Cancer Support Community Inflation Reduction Act (IRA) Summit - Patient Voices in Government Drug Affordability Reviews August 2025: Strength in Numbers: Coalitions Amplifying Patient Voices in CMS Decision-Making June 2025: Women in Government - Challenges in Access: 340B, Alternative Funding Programs, & PDABs June 2025: Colorado PDAB: How New Upper Payment Limits Impact Prescribers & Patients May 2025: ISPOR - PDAB Concerns & Opportunities